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Abstract 
Deficiency of cytochrome c oxidase activity was established in a girl born to consanguineous parents. She showed symptoms of 
dysmaturity, generalized hypotonia, myoclonic seizures and progressive r spiratory failure, leading to death on the seventh day of life. 
Structural abnormalities of the central nervous ystem consisted of severe cerebellar hypoplasia nd optic nerve atrophy. Biochemical 
analysis of a muscle biopsy specimen demonstrated deficiency of cytochrome c oxidase activity. Cultured fibroblasts from this patient 
also showed a selective decrease in the activity of cytochrome c oxidase, excluding a muscle-specific type of deficiency. Further 
investigations in cultured fibroblasts revealed that synthesis, assembly and stability of both the mitochondrial nd the nuclear subunits of 
the enzyme were entirely normal. The steady-state concentration of cytochrome c oxidase in the fibroblasts of the patient was also 
normal, suggesting that the kinetic properties of the enzyme were altered. Analysis of the kinetic parameters of cytochrome c oxidase 
demonstrated anaberrant interaction between cytochrome c oxidase and its substrate, cytochrome c, most likely because of a mutation in 
one of the nuclear subunits of the enzyme. 
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1. Introduction 
Cytochrome c oxidase (complex IV) is the terminal 
enzyme of the respiratory chain. It catalyses the transfer of 
electrons from reduced cytochrome c to oxygen and con- 
serves the free energy of this reaction by pumping protons 
across the mitochondrial inner membrane. The enzyme is 
composed of thirteen different subunits, of which the three 
largest ones are encoded by mitochondrial DNA (mtDNA). 
The other ten subunits are products of nuclear genes that 
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are synthesized in the cytoplasm and transported into the 
mitochondria where they are processed to the mature form 
and assembled with the mitochondrial subunits [1]. The 
subunits encoded by mtDNA constitute the catalytic core 
of the enzyme: they contain the binding site for cy- 
tochrome c and the prosthetic groups, and they are in- 
volved in proton pumping [2]. The function(s) of the 
nuclearly encoded subunits have not yet been elucidated. 
These subunits might be involved in the process of assem- 
bly of a functional enzyme [3], and/or  might bind ligands 
that regulate the catalytic activity of the enzyme [4-7]. A 
regulatory function is supported by the presence of mus- 
cle-specific isoforms of a few nuclear subunits in mam- 
malian cytochrome c oxidase [8,9]. 
Deficiency of cytochrome c oxidase activity is fre- 
quently observed in patients with mitochondrial en- 
cephalomyopathies [10,11]. Biochemically, these deficien- 
cies can be classified in four main categories on the basis 
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of the origin and function of the gene products that are 
involved in the biogenesis of the enzyme. In the first 
group, the deficiency is caused by mtDNA deletions (as is 
frequently the case in the Kearns-Sayre syndrome and 
chronic progressive xternal ophthalmoplegia), by deple- 
tion of mtDNA, or by point mutations in mitochondrial 
tRNA genes [10,12]. These types of mtDNA aberration do 
not lead to selective loss of cytochrome c oxidase activity: 
the activity of the other enzyme complexes that contain 
subunits encoded by mtDNA will also be reduced. In the 
second group, the disorder is based on mutations of nu- 
clear genes for proteins that are involved in mitochondrial 
biogenesis, for instance in import or assembly of nuclearly 
encoded mitochondrial proteins. Such disorders are proba- 
bly rare, but when they occur cytochrome c oxidase will 
again not be affected exclusively [13]. The third group 
consists of deficiencies that are due to mutations in the 
mitochondrial genes for subunits of cytochrome c oxidase. 
So far, this type of defect has only been described in a 
preliminary paper [14]. The fourth group is formed by 
deficiencies due to mutations in nuclear genes encoding 
subunits of cytochrome c oxidase, or because of defects in 
the regulation of the expression of genes for the different 
isoforms. The latter type of defect has been proposed as an 
explanation for cases of benign, muscle-specific y- 
tochrome c oxidase deficiency [8,10], but experimental 
proof is still lacking. Many cases of Leigh's syndrome are 
most likely based on defects in nuclear genes for subunits 
of cytochrome c oxidase that do not show tissue-specific 
expression [10,11,15], but the mutations in question have 
yet to be identified. 
In general, the concentration of the enzyme is reduced 
in tissues or cultured cells from patients with a decreased 
cytochrome c oxidase activity [8,10,16], indicating that 
assembly or stability of the enzyme are affected. In con- 
trast, here we describe a case of selective deficiency of 
cytochrome c oxidase where the amount of enzyme was 
entirely normal. However, the affinity of the enzyme for 
its substrate, cytochrome c, was significantly decreased. 
The results clearly suggest hat mutations in the nuclear 
subunits can affect the catalytic activity of cytochrome c 
oxidase. 
2. Materials and methods 
2.1. Patient 
The clinical data of the patient will be described in 
detail elsewhere (P.G. Barth et al., unpublished ata). In 
short, the female patient was born after an uneventful 
pregnancy as the first child to consanguineous (first 
cousins) parents of Moroc origin. Severe, persistent hypo- 
tonia and myoclonic seizures were observed from the first 
day of life. Ophthalmoscopy revealed bilateral optic nerve 
atrophy. Laboratory investigations showed no other abnor- 
malities than an elevated concentration of lactate acid in 
the cerebrospinal fluid. Magnetic resonance imaging on the 
fourth day of life showed marked hypoplasia of the cere- 
bellum, in particular of the cerebellar hemispheres. The 
girl died at the age of seven days from progressive r spira- 
tory failure probably due to combined neuromuscular in- 
sufficiency and cerebral dysfunction. Muscle and skin 
biopsy specimens were collected within 1 h after death and 
immediately processed for further analysis. Examination of 
the muscle tissue by light microscopy showed no ragged 
red fibres. Analysis of several mitochondrial enzymes in 
muscle homogenates revealed a selective decrease in the 
activity of cytochrome c oxidase. 
2.2. Fibroblast cultures 
Fibroblasts derived from the patient and from different 
healthy controls were cultured in Dulbecco's modified 
Eagle medium (DME) containing 1 mM pyruvate and 
supplemented with 10% heat-inactivated fetal calf serum 
(FCS), at 37 ° C in a humidified atmosphere of 10% CO 2 in 
air [16,17]. Cells from exponentially growing cultures were 
collected as described before [16,18]. The cell pellet was 
resuspended in phosphate buffered saline (PBS) and the 
cell concentration was determined using a counting cham- 
ber. The cell suspension was divided in small portions, 
frozen in liquid nitrogen and stored at -80  ° C. 
2.3. Metabolic labeling 
After removing the normal culture medium, fibroblasts 
from exponentially growing cultures were rinsed twice 
with PBS and cultured in methionine-free DME containing 
1 mM pyruvate and supplemented with 10% heat-in- 
activated FCS in a humidified atmosphere of 10% CO 2 in 
air. After 1 h, [35S]methionine (specific activity > 960 
Ci/mmol) was added to a final concentration of 20 /xCi 
per ml. At various time points, cells were collected by 
centrifugation as described above. In pulse-chase xperi- 
ments, the [3SS]methionine containing medium was re- 
placed by pre-incubated complete DME containing 1 mM 
pyruvate and 10% FCS after rinsing the cells four times 
with PBS. In a number of experiments, emetine was used 
to block the synthesis of nuclear-encoded proteins [19]. 
Emetine was added 10 min before the addition of labeled 
methionine, to a final concentration f 100 /zg/ml. 
2.4. Immunoprecipitation 
The volume of samples containing about 5 • 10  6 fibrob- 
lasts was adjusted to 1 ml with PBS containing 1 mg of 
bovine serum albumin/ml and 2.5 mM phenylmethyl- 
sulphonyl fluoride. Lauryl maltoside (final concentration 
1.5%) was added to solubilize the ceils and to extract 
membrane proteins. The samples were left on ice for 30 
min and then centrifuged for 1 min in a microfuge at 
L.G.J. Nijtmans et al. / Biochimica et Biophysica Acta 1270 (1995) 193-201 195 
12 000 x g. The supematants were used for immunoprecip- 
itation by incubation overnight with antibodies coupled to 
protein A-Sepharose 4B beads as described before 
[16,18,20]. The immunoprecipitates were eluted by incu- 
bating the beads in sample buffer (4% sodium dodecyl 
sulphate, 20% glycerol in 10 mM Tris-HC1, pH 6.8) at 
37 ° C for 2 h. After centrifugation, the eluates were loaded 
on to 15% polyacrylamide gels and subjected to elec- 
trophoresis as described by Sch~igger and Von Jagow [21]. 
In the case of metabolic labeling experiments, the gels 
were dried under vacuum and labeled proteins were visual- 
ized by fluorography [22]. Autoradiographic signals after 
electrophoresis of 3sS-labeled proteins were quantified on 
gels using a Phosphorlmager TM (Molecular Dynamics, 
Sunnyvale, USA). Gels containing unlabeled proteins were 
stained by silver [20]. 
2.5. Antisera 
Subunits I, II, and III of mammalian cytochrome c
oxidase are encoded by the mitochondrial genome, the 
remaining ten smaller subunits are encoded by nuclear 
genes. According to their electrophoretic mobility these are 
referred to as subunits IV, Va, Vb, Via, VIb, VIc, VIIa, 
VIIb, VIIc, and VIII, respectively [20]. Human cytochrome 
c oxidase occurs in two isoforms. One form is present in 
skeletal muscle and heart and contains muscle-type forms 
of subunits Via and VIIa. The other form of cytochrome c 
oxidase is present in all other tissues, including cultured 
cells, and contains the so-called liver-type forms of sub- 
units Via and VIIa [8,9,20,23,24]. A polyclonal antiserum 
against cytochrome c oxidase from bovine heart was raised 
in rabbits. The properties of this antiserum have been 
described in detail before [16,18,20,25,26]. In short, this 
antiserum precipitates the assembled enzyme complex from 
cell or tissue homogenates solubilized with lauryl malto- 
side: after immunoprecipitation and electrophoresis all the 
subunits are detectable with conventional staining meth- 
ods. Some of the subunits are under-represented in the 
immunoprecipitated nzyme, probably because of their 
partial oss from the enzyme complex by distortions in the 
interactions between the subunits due to binding of the 
antiserum. The antiserum precipitates unassembled nucle- 
arly encoded subunits, except subunit VIII. Mitochondrial 
subunits (and subunit VIII) are, however, only precipitated 
if these are part of the assembled enzyme complex. The 
antiserum does not discriminate between both isoforms of 
cytochrome c oxidase. 
2.6. Two-dimensional e ectrophoresis 
Two-dimensional e ectrophoresis was performed using 
a modification of the method described by Sch~igger and 
Von Jagow (P. Klement et al., unpublished ata) [27]. This 
method allows analysis of the molecular mass and the 
composition of (mitochondrial) enzyme complexes. In the 
first dimension separation according to molecular mass of 
these large complexes occurs under native conditions, and 
in the second dimension where electrophoresis i  per- 
formed under denaturating conditions, the individual sub- 
units of the complexes are resolved. Isolation of the com- 
plexes prior to electrophoresis by for instance immuno- 
precipitation is not required, which reduces the possibility 
of losing one or more subunits during isolation of a 
complex. Crude mitochondria were used as starting mate- 
rial for two-dimensional electrophoresis, and were ob- 
tained by incubating 1 • 10  6 cells/ml PBS for 10 min at 
4 ° C with 20 /zg of digitonin [28,29]. The samples were 
centrifuged for 1 min at 12000 ×g in a microfuge to 
obtain a mitochondrial pellet. The gels were stained with 
silver [20]. 
2. 7. Mitochondrial functions in fibroblasts 
Mitochondrial ATP synthesis was measured in fibrob- 
lasts from exponentially growing cultures, permeabilized 
with low concentrations of digitonin (1 /xg/106 cells) 
[30]. ATP synthesis was initiated by the addition of ADP 
to a final concentration of 10 raM. Glutamate (10 mM) + 
malate (2 mM) or pyruvate (10 mM)+ malate (2 mM) 
were used as substrates for oxidative phosphorylation via 
complexes I, III and IV. Succinate (10 mM) (+2 /zg 
rotenone/ml to inhibit complex I) was used as a substrate 
for oxidative phosphorylation via complexes II, III and IV. 
Ascorbate (10 mM)+ tetramethylphenylenediamine (0.5 
mM) were used as substrates for ATP production via 
complex IV. In the latter case 2 /xg rotenone/ml and 2 /zg 
antimycin/ml were present to inhibit the activities of 
complex I and III, respectively. 
The activity of mitochondrial enzymes and the protein 
content of the cells were determined in freshly prepared 
cell lysates, obtained by treatment with lauryl maltoside as 
described under immunoprecipitation. The activity of cy- 
tochrome c oxidase was measured spectrophotometricaUy 
[20] at 25°C in 25 mM phosphate buffer (pH 7.4), using 
20 /xM reduced bovine heart cytochrome c as the sub- 
strate, and is expressed as the first-order reaction-rate 
constant, k. The steady-state kinetics of the enzyme were 
measured under the same conditions, but the concentration 
of reduced cytochrome was varied between 1 and 67 
/zM. The final concentration of cytochrome ¢ oxidase in 
these measurements was calculated via quantitative im- 
munoprecipitation as described before [20]. Kr, and Vma × 
values were determined for the high-affinity reaction by 
computer analysis of the data which were expressed as 
reversed Eadie-Hofstee plots. 
The citrate synthase activity was measured according to 
the method of Srere [31]. The activities of complex II and 
Ili were measured at 25 ° C in 25 mM phosphate buffer (pH 
7.4), containing 1 mM MgCI 2. Succinate (10 mM) was 
used as substrate for measurements of complex II, where 
the reduction of dichlorophenolindophenol (50 #M) was 
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followed in the presence of rotenone (2 /xg/ml), an- 
timycin (2 /zg/ml) and KCN (2 mM). Antimycin (2 
/xg/ml) sensitive complex III activity was determined in 
the presence of both rotenone (2 /zg/ml) and KCN (2 
mM), using decylubiquinol (80 /xM) as substrate and 
oxidized bovine heart cytochrome c (40 /xM) as electron 
acceptor. The enzymatic activities are expressed as 
nmol /mg protein in cell lysates/min. The protein content 
of the samples was estimated using a modified Lowry 
method [32]. 
2.8. Sequencing of the gene for subunit H 
Mitochondrial DNA sequences were amplified by poly- 
merase chain reaction from DNA isolated from fibroblasts 
of the patient. Primers were selected by means of computer 
program Primer (S.E. Lincoln, M.J. Daly and E.S. Lander, 
MIT Center for Genomic Research and Whitehead Insti- 
tute for Biomedical Research, Cambridge, USA). Primers 
were synthesized on an Expedite Nucleic Acid Synthesis 
System TM (Milllipore, Bedford, USA). To amplify the 
mtDNA fragment corresponding to nucleotide number 
7578-8303 appropriate forward and reverse primers were 
synthesized, and to sequence this fragment internal primers 
(forward and reverse) for the nucleotide numbers 7771- 
7849 and 8009-8089. The polymerase chain reaction pro- 
gram was: 95 ° C, 30 s; 55 ° C, 60 s; and 72 ° C, 90 s for 30 
cycles. The polymerase chain reaction products were puri- 
fied by electrophoresis and recovered from the gel using 
Magic TM PCR Preps column (Promega, Madison, USA). 
The sequencing reactions were carried out according to 
standard methods, using [355]dATP and the T 7 polymerase 
sequencing kit (Sequenase, USB, Cleveland, USA) 
3. Results 
3.1. Analysis of the activities of mitochondrial enzymes in 
cultured fibroblasts 
The activity of cytochrome c oxidase in cultured fibro- 
blasts from the patient, expressed per mg cellular protein, 
was 25% of the corresponding mean control value. The 
activities of other mitochondrial enzymes were entirely 
normal (Table 1). Deficiency of cytochrome c oxidase 
activity was therefore not limited to muscle of the patient. 
This ruled out muscle-specificity of the primary defect, 
such as involvement of the muscle-type specific subunits 
Via and VIIa. Furthermore, this allowed us to study the 
biosynthesis and other properties of the enzyme from the 
patient in detail. 
3.2. Synthesis and assembly of cytochrome c oxidase 
Fig. 1 shows the results of studies on the synthesis, 
assembly and degradation of subunits of cytochrome c
oxidase in fibroblasts from the patient and in control 
fibroblasts. Experiments with intact cells labeled in the 
presence of emetine indicated that the expression of mito- 
chondrial genes in fibroblasts from the patient was compa- 
rable to that in control fibroblasts, both with respect o the 
amount of label incorporated into mitochondrial gene prod- 
EONTROL PATIENT 
Fig. 1. Synthesis and stability of mitoehondrial and nuclear subunits of cytochrome c oxidase in control fibroblasts and fibroblasts from the patient. 
Fibroblasts were labeled with [35S]methionine for 1 h or 2 h. After labeling for 2 h, the cells were cultured further in the absence oflabeled methionine for 
3 h or 21 h. The subunits of cytochrome c oxidase were isolated by immunoprecipitation fr m cells solubilized with lauryl maltoside. The same number of 
cells (0.5 • 106) was used for each experiment. COX: cytochrome c oxidase. 
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Table 1 
Mitochondrial functions in cultured fibroblasts 
Patient Controls 
Enzyme activities 
citrate synthase 79 (2) 78 (51; 58-80) 
complex II 6.2 (2) 7.6 (9; 5.6-7.8) 
complex III 9.6 (2) 10.7 (7; 10.3-13.1) 
complex IV 0.15 (2) 0.58 (51; 0.45-0.62) 
ATP production 
glutamate + malate 1355 (3) 1393 (7; 1104-1402) 
pyruvate +malate 1231 (3) 1239 (6; 1056-1320) 
succinate 977 (3) 997 (6; 672-1116) 
ascorbate + TMPD 700 (2) 703 (3; 688-725) 
The activity of mitochondrial enzymes were measured in fibroblasts 
solubilized with lauryl maltoside. The activities are expressed as k per 
min per mg protein (cytochrome c oxidase) or as nmol per min per mg 
protein (other enzymes), as described in Section 2. The ATP production 
was measured in fibroblasts permeabilized with digitonin and is ex- 
pressed as nmol ATP per h per mg protein. The mean values obtained in 
different experiments are shown. The assays with fibroblasts from the 
patient were performed in duplicate, the number of independent experi- 
ments is indicated between brackets. The assays with control fibroblasts 
were also performed in duplicate, the number of independent experiments 
and the minimal and maximal values obtained for various control fibrob- 
lasts are given between brackets. TMPD: tetramethyl phenylenediamine. 
ucts and with respect to the molecular mass of these 
products (data not shown). Immunoprecipitation f sub- 
units of cytochrome c oxidase after labeling in the absence 
of emetine demonstrated that the rate of synthesis of 
nuclear subunits also did not differ significantly between 
fibroblasts from the patient and control fibroblasts (Fig. 1, 
pulse-experiments). The same was the case for the turnover 
rate of the subunits, determined in pulse-chase experiments 
(Fig. 1). Since the antiserum that was used only precipi- 
tates mitochondrial subunits of cytochrome c oxidase when 
these are assembled with nuclear subunits (see Section 2), 
the assembly of mitochondrial nd nuclear subunits in cells 
from the patient was apparently normal: the ratio between 
the signals of, e.g., subunit II and IV was always compara- 
ble to that seen in control cells at the same pulse or 
pulse-chase time. 
3.3. Concentration of cytochrome c oxidase 
Fig. 2 shows an example of two-dimensional elec- 
trophoresis of mitochondrial enzyme complexes from con- 
trol fibroblasts and those from the patient. The complexes 
could be easily identified because of the mobility in the 
first dimension and the characteristic electrophoretic pat- 
tern of the subunits in the second dimension [27]. In 
addition, we confirmed the position of cytochrome c oxi- 
dase by immunoblotting of the first-dimension and 
second-dimension gels; immunoreactivity was found only 
in the area where the assembled enzyme was expected 
because of its molecular mass. A comparison of the con- 
centrations of complexes I, II, III, IV, and V derived from 
the same number of control or patient's fibroblasts howed 
no differences: the concentration f the complexes, includ- 
ing that of complex IV, was normal in fibroblasts from the 
patient. Careful analysis of the staining intensity of the 
subunits of cytochrome c oxidase also did not reveal 
significant differences in concentration of individual sub- 
units between controls and the patient. 
3.4. Mobility of nuclear subunits of cytochrome c oxidase 
Minor differences in mobility of individual nuclear 
subunits of cytochrome c oxidase will not be noticed 
P C 
I vm w H I. v,]II Iy I! COX 
subunif: 
-! 
:IIIII 
-IV 
-Va, b 
-VIa, b,c 
:'VII b ~j j C 
-VIII 
Fig. 2. Composition and concentration f mitochondrial enzyme complexes in control fibroblasts and fibroblasts from the patient. Mitochondria obtained 
by digitonin treatment of control fibroblasts (C) or fibroblasts from the patient (P) were used as starting material for 2D-electrophoresis. The gels were 
stained by silver. I, II, III, IV, V: complexes I, I1, III, IV and V. The position of these complexes after electrophoresis in the first dimension is indicated at 
the top. COX: cytochrome c oxidase (complex IV). The position of the individual subunits of cytochrome c oxidase after electrophoresis in the second 
dimension is indicated on the right. 
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under the experimental conditions used above. In view of 
this, longer gels on which a much higher degree of resolu- 
tion can be obtained [18,20] were used to analyse the 
mobility of the nuclear subunits. Before electrophoresis, 
cytochrome c oxidase was isolated from the same number 
of control and patient's fibroblasts by immunoprecipita- 
tion. The intensive staining of polypeptides derived from 
the antiserum in the upper part of the gel obscures the 
mitochondrial subunits [16,20], but the nuclear subunits 
were clearly visible and differences in mobility were not 
observed (Fig. 3). In addition, the concentration of the 
individual subunits as judged by silver staining was com- 
parable between controls and patient, except for that of 
subunit VIII (Fig. 3, right side). 
3.5. Kinetic analysis of cytochrome c oxidase 
The steady-state kinetic reactions of cytochrome c oxi- 
dase in fibroblasts from the patient and in control fibrob- 
lasts are shown in the form of reverse Eadie-Hofstee plots 
in Fig. 4. Under conditions of low ionic strength, biphasic 
plots are obtained for cytochrome c oxidase reactions that 
show a high-affinity and a low-affinity phase [20], but at 
R 
I- 
E P R C P 
II. 
I l l -  
IV- 
vg; 
Vlab: 
C _ 
VIII- 
Fig. 3. Mobility of nuclear subunits of cytochrome c oxidase in control 
fibroblasts and fibroblasts from the patient. Cytochrome c oxidase was 
isolated from 8-106 control fibroblasts (C) or 8.106 fibroblasts from the 
patient (P) by immunoprecipitation. The gels were stained with silver. R: 
human heart cytochrome c oxidase, used as reference [20]. The position 
of the subunits of human cytochrome c oxidase is indicated on the left. In 
order to show subunit VIII more clearly, the right-hand part of Fig. 3 
shows an overexposed picture of the same gel as shown in the left part. 
I  
1 • 
i 
lb 2b 30 
V (nmot/min/mg proteinl 
Fig. 4. Steady-state kinetics of cytochrome c oxidase in control fibro- 
blasts and in fibroblasts from the patient. The activity of cytochrome c 
oxidase was measured in fibroblasts olubilized with lauryl maltoside at 
concentrations of reduced bovine heart cytochrome c that ranged from 1 
to 67/~M. The rate of oxidation of cytochrome c is plotted against he 
oxidation rate at a given substrate concentration (reversed Eadie-Hofstee 
plots). The combined results of 2 independent experiments are shown. 
The lines indicate the reaction kinetics for the high-affinity phase. O: 
control fibroblasts; O: patient fibroblasts. 
intermediate ionic strength as used here, the low-affinity 
phase tends to disappear. Analysis of the data shown in 
Fig. 4 resulted in a value of Vma x for the high-affinity 
reaction of 14 nmol per min per mg cell protein in control 
cells, in the patient it proved to be 6 nmol per min per mg 
protein. Analysis of the amount of cytochrome c oxidase 
using quantitative immunoprecipitation [20] showed that 1 
mg of cellular protein per ml equalled a cytochrome c 
oxidase concentration f 0.025/xM, both in control fibrob- 
lasts and in fibroblasts from the patient. Therefore, the 
maximal turnover number per molecule cytochrome c
oxidase from control fibroblasts was 9.3 per s, and 4 per s 
for cytochrome c oxidase from the patient. Calculation of 
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the K m values showed more significant differences: in 
control cells the K m of the enzyme for reduced bovine 
cytochrome c was 40 /zM whereas the K m for reduced 
cytochrome c of cytochrome c oxidase from the patient 
was increased to 160 /xM. 
3.6. Mitochondrial function 
Table 1 shows that there were no differences between 
cells from the patient and control fibroblasts when their 
capacity for mitochondrial ATP production was compared. 
ATP production as the result of oxidation of NADH 
(derived from either glutamate or pyruvate) via complexes 
I, III and IV, and ATP production resulting from the 
oxidation of succinate via complexes II, III and IV was 
normal in the patient's fibroblasts, indicating that the 
reduced activity of cytochrome c oxidase was not limiting 
in this respect. ATP production measured in the presence 
of inhibitors of complex I and complex III was also not 
affected when ascorbate + tetramethylphenylenediamine 
were used as artificial electron donors for complex IV. 
3. 7. Sequence analysis of  the gene for subunit H 
The sequence of the gene for subunit II of cytochrome 
c oxidase from the patient proved to be identical to the 
Cambridge sequence [33]. 
4. Discussion 
We identified selective deficiency of cytochrome c
oxidase activity in a patient who presented shortly after 
birth with severe hypotonia nd severe cerebellar hypopla- 
sia and who died of progressive respiratory failure on the 
seventh day of life. The only major abnormality in the 
results of extensive clinical laboratory investigations was a 
moderately elevated level of lactate in the cerebrospinal 
fluid, compatible with mitochondrial dysfunction in brain 
tissue. The hypoplastic cerebellar hemispheres, docu- 
mented by cranial magnetic resonance imaging, indicated 
that normal growth and development of the fetal brain 
were affected by the primary defect. Cerebellar hypoplasia 
can be caused by various metabolic and non-metabolic 
diseases [34], and the findings in this patient suggest hat 
deficiency of cytochrome c oxidase may be another cause. 
Studies in cultured fibroblasts from the patient showed 
also a selective deficiency of cytochrome c oxidase activ- 
ity, but metabolic labeling experiments demonstrated that 
the rate of synthesis and turnover of mitochondrial and 
nuclear subunits of cytochrome c oxidase did not differ 
between patient and control cells, suggesting that the 
steady-state concentration of the enzyme complex was 
normal (Fig. 1). This was confirmed by the results from 
two-dimensional e ectrophoresis. The position of the as- 
sembled enzyme complex after electrophoresis in the first 
dimension was the same as that of normally-sized cy- 
tochrome c oxidase and the steady-state concentration of
individual subunits of cytochrome c oxidase, visualized by 
staining after electrophoresis in the second dimension, was 
comparable in fibroblasts from the patient and control cells 
(Fig. 2). The reduced activity of the enzyme in the patient 
was therefore not due to a reduced amount of complex IV, 
but to a diminished activity per molecule of the enzyme. 
To investigate the diminished activity of cytochrome c 
oxidase from the patient in more detail, the kinetics of the 
reactions of the enzyme were studied. These studies were 
performed at intermediate ionic strength and the reactions 
were analyzed for the high-affinity phase, since these 
conditions are supposed to resemble the physiological 
situation [20,35,36]. This analysis howed that the activity 
per molecule of enzyme (or turnover number) was indeed 
decreased in the patient, and, moreover, that the K m for 
reduced bovine cytochrome c was 4-fold increased (Fig. 
4). In view of the difficulty to obtain sufficient material for 
classical kinetic assays with purified mitochondrial en- 
zymes from patients, the analyses were carried out with 
supernatants of cells treated with lauryl maltoside. Using 
the same approach, the kinetic parameters for human cy- 
tochrome c oxidase from different issues were compared 
in a previous tudy [20]. The values for K m and maximal 
turnover number per molecule enzyme obtained in that 
study for cytochrome c oxidase from, e.g., human kidney 
are well comparable to those found in the present study for 
control fibroblasts. 
The activity of cytochrome c oxidase from the patient 
showed no abnormalities when ascorbate and tetramethyl 
phenylenediamine w re used as artificial electron donors 
in experiments with permeabilized fibroblasts (Table 1). 
The interaction (binding and dissociation) of cytochrome c 
and cytochrome c oxidase is not rate-limiting for the 
activity under the latter conditions, whereas this is the case 
when activity measurements are carried out with cy- 
tochrome c as substrate [36]. The reduction of cytochrome 
c oxidase activity in the patient is thus most probably 
related to defects in the interaction with cytochrome c and 
not caused by defects that influence the electron transfer or 
proton-pumping properties of the enzyme. The most obvi- 
ous explanation for this would be a mutation in subunit II 
of the enzyme, since this subunit contains the cytochrome 
c binding site [37]. However, sequence analysis of the 
entire gene revealed no mutations, the genes for subunits I 
and III showed no major rearrangements, and the expres- 
sion of all three mitochondrial genes for subunits of cy- 
tochrome c oxidase was completely normal. 
Alternatively, a mutation in a nuclear gene for one of 
the subunits of cytochrome c oxidase might be the cause 
of the aberrant kinetic parameters of the enzyme in the 
patient. This possibility would suggest an autosomal reces- 
sive mutation. This could be in line with both the consan- 
guinity of the parents of the patient and the birth of a 
second, healthy child. The postulated mutation in a nuclear 
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subunit of the enzyme should indirectly influence the 
binding of cytochrome c to explain our findings. Possible 
regulation of the activity of cytochrome c oxidase by 
binding to the nuclear subunits of effectors such as nu- 
cleotides or hormones was proposed already a long time 
ago [38], and regulation of the activity of the mammalian 
enzyme by binding of ATP to subunit Via has been 
demonstrated [39]. Possible differences in modulation by 
ATP binding can, however, not account for the different 
kinetics of cytochrome c oxidase from the patient, since 
the activity was normal when tested in the presence of 
ATP and ADP (in permeabilized cells), but abnormal in 
their absence (as measured with the solubilized enzyme). 
Mutations of subunits Via and VIIa can also be excluded, 
since deficiency of cytochrome c oxidase activity was 
found both in cultured fibroblasts (containing the liver-type 
forms of these subunits) and in muscle (containing the 
muscle-type forms) from the patient. 
The postulated mutation does not result in obvious 
differences in molecular mass of one of the subunits: the 
electrophoretic mobility of the nuclear subunits of cy- 
tochrome c oxidase were the same in the patient and 
control (Fig. 3). Apparently, it also does not influence the 
assembly of the enzyme, since the steady-state concentra- 
tion and the molecular mass of the enzyme were normal 
after native electrophoresis (Fig. 2). Isolation of the en- 
zyme by (quantitative) immunoprecipitation from fibrob- 
lasts from the patient did, however, frequently result in 
under-representation of subunit VIII (Fig. 3). Since subunit 
VIII can only be precipitated when it is part of the 
assembled enzyme complex (see Section 2) this suggests a
looser association of the subunits in cytochrome c oxidase 
from the patient han in the controls. In turn, this might be 
due to the postulated (point) mutation in one of the nuclear 
subunits. Experiments to determine the nucleotide se- 
quence of the genes encoding the nuclear subunits are 
presently in progress. The results will not only help to find 
the molecular basis of the altered kinetics of the enzyme in 
this patient, but also increase the insight about the function 
of the nuclear subunits in the regulation of the activity of 
cytochrome c oxidase. 
This is the first detailed description of a cytochrome c 
oxidase deficiency that is based on abnormal kinetic prop- 
erties of the enzyme, expressed in cultured fibroblasts and, 
in contrast o other cases of cytochrome c oxidase defi- 
ciencies [11,40-43] not associated with reduced concentra- 
tions of the enzyme. A previous study, in which we 
compared the concentration, using immuno-flow cytome- 
try, and the activity of the enzyme in cultured fibroblasts 
derived from patients with selective deficiency of cy- 
tochrome c oxidase showed a normal concentration, but a 
decreased activity in two of the nine tested cell lines [16]. 
Deficiencies in activity that are based on alterations of the 
kinetic properties of the enzyme might thus not be that 
rare. The clinical and pathological consequences of this 
type of cytochrome c oxidase deficiency can only be 
roughly estimated. Differential tissue-involvement, as was 
the case in our patient, could reflect the different require- 
ments for cytochrome c oxidase activity, or differences in 
the in vivo regulation of the activity of the enzyme. In 
cultured fibroblasts, the deficiency did not lead to a re- 
duced capacity for ATP production, suggesting that the 
reduced activity of cytochrome c oxidase was not limiting 
for this process. Since the patient did not show major 
metabolic disturbances, the diminished cytochrome c oxi- 
dase activity might likewise not have affected normal iver 
function. The defect appeared, however, to influence mus- 
cle function and especially the development of the cerebel- 
lum. 
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